Status
Conditions
Treatments
About
The goal of this clinical trial is to evaluate the effectiveness of immersive virtual reality (VR) training on improving infection control preparedness among healthcare workers during the Hajj pilgrimage in Saudi Arabia.
The main questions this study aims to answer are:
Does VR training improve healthcare workers' knowledge, confidence, and preparedness for infection control compared to traditional training?
Are there differences in outcomes between the VR training and traditional lecture-based education?
Full description
This study explores the use of virtual reality (VR) technology to train healthcare practitioners in infection control during the Hajj pilgrimage, one of the largest annual gatherings in the world. Infection control is critical in such mass gatherings to prevent the spread of contagious diseases and ensure the safety of millions of attendees.
The study is designed as a randomized controlled trial to evaluate how effective VR training is in improving healthcare workers' skills, readiness, and confidence in infection prevention and control measures. By immersing participants in realistic, interactive scenarios using VR, the training aims to better prepare them for the complex and fast-paced environment of Hajj healthcare services.
Through this research, we aim to demonstrate whether VR-based training can enhance clinical preparedness more effectively than traditional training methods. The ultimate goal is to support safer healthcare delivery during Hajj and potentially apply this innovative approach to other high-risk healthcare settings worldwide.
This study also considers cultural adaptation to ensure the VR training is relevant and meaningful for healthcare workers in Saudi Arabia. The findings could have a significant impact on how infection control education is delivered, improving outcomes for both practitioners and patients.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
200 participants in 2 patient groups
Loading...
Central trial contact
Mohammed O Alanazi, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal